Aurobindo Pharma on August 12 posted a 1.68% decline in its consolidated net profit to Rs 769.97 crore for the quarter ended on June 30.
An investment of Rs 1 lakh at inception would now have grown to a corpus of Rs 87 lakh, while a SIP of Rs 10,000/month would have grown to Rs 9.57 cr
He said the Indian economy is better-placed to handle post-Covid woes and it is not a fair perception that PSUs are perpetual wealth destroyers
Following the transaction, HDFC AMC has increased its stake in LG Balakrishnan & Bros to 7.29% from 5.29% held earlier.